In case you missed it

In the Sunday Globe:

Duke neuro-oncologist Dr. Henry Friedman (left) wrote a provocative paper last year chastising the medical community for approaching glioblastomas as death sentences. Noting that a small but growing number of patients have achieved long-term survival, he pushed for supplementing the standard treatment with additional therapies, including drugs that have not been FDA-approved for this illness. And, more broadly, he advocates a change in attitude.

Efforts to keep pharmaceuticals out of the water supply are ramping up in Massachusetts, but they are running into legal and financial constraints that make the proper disposal of drugs difficult.

In Saturday's Globe:

Pardis Sabeti, a pioneering geneticist and assistant professor at Harvard, has a second life as a singer/songwriter. Based at the Broad Institute in Cambridge, Sabeti devotes much of her energies to mentoring young women gifted at science and math - and who think it's pretty cool to have a lab director who could be touring with Coldplay, all things considered.

Jonathan Wadleigh (left), who helped found an advocacy group mainly for those with hemophilia who were infected with HIV through blood products, died of liver cancer June 4 in Beth Israel Deaconess Medical Center. He was 62 and lived in Brookline. He was the lead plaintiff in a class action lawsuit that, after winding its way through the courts, resulted in a $670 million settlement from four drug companies that manufactured the blood products.